We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$1.35B
AUM Growth
+$137M
Cap. Flow
+$72.8M
Cap. Flow %
5.38%
Top 10 Hldgs %
59.71%
Holding
2,379
New
211
Increased
969
Reduced
524
Closed
145

Sector Composition

Rank Sector Weight
1 Financials 5.71%
2 Technology 5.69%
3 Consumer Staples 4.7%
4 Consumer Discretionary 4.47%
5 Healthcare 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFN
2301
DELISTED
Infinera Corporation Common Stock
INFN
-2,585
Closed -$14K
VIRX
2302
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$0 ﹤0.01%
2
SMAR
2303
DELISTED
Smartsheet Inc.
SMAR
$0 ﹤0.01%
1
TUP
2304
DELISTED
Tupperware Brands Corporation
TUP
$0 ﹤0.01%
39
-1,151
-97% -$12.6K
ATRI
2305
DELISTED
Atrion Corp
ATRI
-3
Closed -$2K
SBOW
2306
DELISTED
SilverBow Resources, Inc.
SBOW
-124
Closed -$1K
CEM
2307
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-180
Closed -$10K
CSTR
2308
DELISTED
CapStar Financial Holdings, Inc
CSTR
$0 ﹤0.01%
22
BFX
2309
DELISTED
BowFlex Inc.
BFX
$0 ﹤0.01%
16
VST.WS.A
2310
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
-608
Closed -$1K
AENZ
2311
DELISTED
Aenza S.A.A.
AENZ
-66
Closed
VRTV
2312
DELISTED
VERITIV CORPORATION
VRTV
$0 ﹤0.01%
3
-4
-57% -$70
GHL
2313
DELISTED
Greenhill & Co., Inc.
GHL
-22
Closed
JHAA
2314
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
-20,000
Closed -$207K
ACGN
2315
DELISTED
Aceragen Inc
ACGN
$0 ﹤0.01%
11
HEXO
2316
DELISTED
HEXO Corp. Common Shares
HEXO
$0 ﹤0.01%
5
MNRL
2317
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$0 ﹤0.01%
14
-16
-53% -$312
ZVO
2318
DELISTED
Zovio Inc. Common Stock
ZVO
$0 ﹤0.01%
100
STON
2319
DELISTED
StoneMor Inc.
STON
$0 ﹤0.01%
336
+186
+124% +$215
GBT
2320
DELISTED
Global Blood Therapeutics, Inc.
GBT
$0 ﹤0.01%
+1
New +$59
ABTX
2321
DELISTED
Allegiance Bancshares
ABTX
-68
Closed -$2K
POLY
2322
DELISTED
Plantronics, Inc.
POLY
-44
Closed -$2K
TPTX
2323
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$0 ﹤0.01%
1
EPZM
2324
DELISTED
Epizyme, Inc
EPZM
$0 ﹤0.01%
4
AFI
2325
DELISTED
Armstrong Flooring, Inc.
AFI
-61
Closed

Similar funds

SignatureFD's Q4 2019 Portfolio in Review

As of Q4 2019, SignatureFD held 2,379 positions worth $1.35B, up 11% from $1.22B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

SignatureFD deployed $72.8M of net new capital in Q4 2019, opening 211 new positions and adding to 969 existing holdings. Its largest new stake was Castle Biosciences: 16,132 shares worth $554K.

By sector, the portfolio is most concentrated in Financials at 5.7% of assets, down from 5.8% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $43M trimmed.

  • SignatureFD's largest Q4 2019 buy was Castle Biosciences: 16,132 shares worth $554K.
  • SignatureFD added most to iShares MSCI USA Value Factor ETF in Q4 2019, an estimated $22.2M increase.
  • SignatureFD's biggest Q4 2019 reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, cutting an estimated $43M.
  • SignatureFD fully exited Berkshire Hathaway Class A in Q4 2019, selling an estimated $1.87M.
  • SignatureFD's ten largest holdings make up 60% of its $1.35B portfolio in Q4 2019.
  • SignatureFD opened 211 new positions and closed 145 in Q4 2019.
  • SignatureFD's portfolio value rose 11% quarter-over-quarter to $1.35B.

Based on SignatureFD's 13F filing for Q4 2019, filed 5 Feb 2020.